Use of AliveCor ECG Monitoring to Replicate ECG Lead Recording

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04472520

Enrollment

Registered

2020-07-15

Start date

2021-01-01

Completion date

2022-12-31

Last updated

2020-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia

Brief summary

The researchers are trying to determine whether the Alivecor device can simulate other electrocardiogram (ECG) leads to record electrical activity.

Interventions

DEVICEAliveCor Heart Monitor

Records single-channel ECG rhythms

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Individuals greater than 18 years old getting an ECG

Exclusion criteria

* Patients unwilling or unable to provide informed consent

Design outcomes

Primary

Measure	Time frame	Description
Electrocardiogram (ECG) QT Interval	1 day	The QT interval represents the time of ventricular activity including both depolarization and repolarization. It is measured from the beginning of the QRS complex to the end of the T wave. Normally, the QT interval is 0.36 to 0.44 seconds

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026